+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

BRIC Reproductive Health Diagnostics Market Outlook to 2036 - Prenatal Screening and Reproductive Hormones and Proteins Tests

  • PDF Icon

    Report

  • 140 Pages
  • May 2026
  • Region: Brazil, China, India, Russia
  • GlobalData
  • ID: 6115323

BRIC Reproductive Health Diagnostics Market Outlook to 2036 - Prenatal Screening and Reproductive Hormones and Proteins Tests

Summary

The analyst’s “BRIC Reproductive Health Diagnostics Market Outlook to 2036” is a comprehensive databook report, covering key market data on the BRIC Reproductive Health Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Prenatal Screening, Reproductive Hormones and Proteins Tests

The BRIC Reproductive Health Diagnostics Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
  • 2025 company share data for Reproductive Health Diagnostics Market.
  • Global corporate-level profiles of key companies operating within the BRIC Reproductive Health Diagnostics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

BRIC Reproductive Health Diagnostics is segmented as follows:

  • Prenatal Screening
  • Reproductive Hormones and Proteins Tests

Reasons to Buy

The BRIC Reproductive Health Diagnostics Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Reproductive Health Diagnostics Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Reproductive Health Diagnostics Market, BRIC
2.1 Reproductive Health Diagnostics Market, BRIC, Revenue ($m), 2024-2036
2.2 Reproductive Health Diagnostics Market, BRIC, Revenue ($m), 2024-2036
2.3 Reproductive Health Diagnostics Market, BRIC, Volume (Units), 2024-2036
2.4 Reproductive Health Diagnostics Market, BRIC, Volume (Units), 2024-2036
2.5 Reproductive Health Diagnostics Market, BRIC, Company Share by Revenue ($m), 2025
3 Reproductive Health Diagnostics Market, Brazil
3.1 Reproductive Health Diagnostics Market, Brazil, Revenue ($m), 2024-2036
3.1.1 Prenatal Screening Market, Brazil, Revenue ($m), by Segment, 2024-2036
3.1.2 Reproductive Hormones and Proteins Tests Market, Brazil, Revenue ($m), by Segment, 2024-2036
3.2 Reproductive Health Diagnostics Market, Brazil, Volume (Units), 2024-2036
3.2.1 Prenatal Screening Market, Brazil, Volume (Units), by Segment, 2024-2036
3.2.2 Reproductive Hormones and Proteins Tests Market, Brazil, Volume (Units), by Segment, 2024-2036
3.3 Reproductive Health Diagnostics Market, Brazil, Average Price ($), 2024-2036
3.4 Reproductive Health Diagnostics Market, Brazil, Company Share by Revenue ($m), 2025
4 Reproductive Health Diagnostics Market, China
4.1 Reproductive Health Diagnostics Market, China, Revenue ($m), 2024-2036
4.1.1 Prenatal Screening Market, China, Revenue ($m), by Segment, 2024-2036
4.1.2 Reproductive Hormones and Proteins Tests Market, China, Revenue ($m), by Segment, 2024-2036
4.2 Reproductive Health Diagnostics Market, China, Volume (Units), 2024-2036
4.2.1 Prenatal Screening Market, China, Volume (Units), by Segment, 2024-2036
4.2.2 Reproductive Hormones and Proteins Tests Market, China, Volume (Units), by Segment, 2024-2036
4.3 Reproductive Health Diagnostics Market, China, Average Price ($), 2024-2036
4.4 Reproductive Health Diagnostics Market, China, Company Share by Revenue ($m), 2025
5 Reproductive Health Diagnostics Market, India
5.1 Reproductive Health Diagnostics Market, India, Revenue ($m), 2024-2036
5.1.1 Prenatal Screening Market, India, Revenue ($m), by Segment, 2024-2036
5.1.2 Reproductive Hormones and Proteins Tests Market, India, Revenue ($m), by Segment, 2024-2036
5.2 Reproductive Health Diagnostics Market, India, Volume (Units), 2024-2036
5.2.1 Prenatal Screening Market, India, Volume (Units), by Segment, 2024-2036
5.2.2 Reproductive Hormones and Proteins Tests Market, India, Volume (Units), by Segment, 2024-2036
5.3 Reproductive Health Diagnostics Market, India, Average Price ($), 2024-2036
5.4 Reproductive Health Diagnostics Market, India, Company Share by Revenue ($m), 2025
6 Reproductive Health Diagnostics Market, Russia
6.1 Reproductive Health Diagnostics Market, Russia, Revenue ($m), 2024-2036
6.1.1 Prenatal Screening Market, Russia, Revenue ($m), by Segment, 2024-2036
6.1.2 Reproductive Hormones and Proteins Tests Market, Russia, Revenue ($m), by Segment, 2024-2036
6.2 Reproductive Health Diagnostics Market, Russia, Volume (Units), 2024-2036
6.2.1 Prenatal Screening Market, Russia, Volume (Units), by Segment, 2024-2036
6.2.2 Reproductive Hormones and Proteins Tests Market, Russia, Volume (Units), by Segment, 2024-2036
6.3 Reproductive Health Diagnostics Market, Russia, Average Price ($), 2024-2036
6.4 Reproductive Health Diagnostics Market, Russia, Company Share by Revenue ($m), 2025
7 Reproductive Health Diagnostics Market Pipeline Products
7.1 Reproductive Health Diagnostics Market Pipeline Products
7.2 Reproductive Health Diagnostics - Pipeline Products by Stage of Development
7.3 Reproductive Health Diagnostics - Pipeline Products by Segment
7.4 Reproductive Health Diagnostics - Pipeline Products by Territory
7.5 Reproductive Health Diagnostics - Pipeline Products by Regulatory Path
7.6 Reproductive Health Diagnostics - Pipeline Products by Estimated Approval Date
8 Overview of Key Companies in BRIC Reproductive Health Diagnostics Market
8.1 Beckman Coulter Inc
8.1.1 Company Overview
8.2 Illumina Inc
8.2.1 Company Overview
8.3 Quidel Corp
8.3.1 Company Overview
8.4 Roche Diagnostics International Ltd
8.4.1 Company Overview
8.5 BGI Genomics Co Ltd
8.5.1 Company Overview
8.6 Siemens Healthineers AG
8.6.1 Company Overview
8.7 F. Hoffmann-La Roche Ltd
8.7.1 Company Overview
8.8 Abbott Laboratories
8.8.1 Company Overview
8.9 Danaher Corp
8.9.1 Company Overview
8.10 Thermo Fisher Scientific Inc
8.10.1 Company Overview
9 Appendix
9.1 Research Methodology
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Benchmarking
9.2 the Analyst Consulting
9.3 Contact Us
9.4 Disclaimer
List of Tables
Table 1: Reproductive Health Diagnostics Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2024-2036
Table 2: Reproductive Health Diagnostics Market, BRIC, Revenue ($m), USD Constant, 2024-2036
Table 3: Reproductive Health Diagnostics Market, BRIC, Volume (Units), 2024-2036
Table 4: Reproductive Health Diagnostics Market, BRIC, Volume (Units), 2024-2036
Table 5: Reproductive Health Diagnostics Market, BRIC, Company Share by Revenue ($m), 2025
Table 6: Reproductive Health Diagnostics Market, Brazil, Revenue ($m), USD Constant, 2024-2036
Table 7: Prenatal Screening Market, Brazil, Revenue ($m), USD Constant, 2024-2036
Table 8: Reproductive Hormones and Proteins Tests Market, Brazil, Revenue ($m), USD Constant, 2024-2036
Table 9: Reproductive Health Diagnostics Market, Brazil, Volume (Units), 2024-2036
Table 10: Prenatal Screening Market, Brazil, Volume (Units), 2024-2036
Table 11: Reproductive Hormones and Proteins Tests Market, Brazil, Volume (Units), 2024-2036
Table 12: Reproductive Health Diagnostics Market, Brazil, Average Price ($), 2024-2036
Table 13: Reproductive Health Diagnostics Market, Brazil, Company Share by Revenue ($m), USD Constant, 2025
Table 14: Reproductive Health Diagnostics Market, China, Revenue ($m), USD Constant, 2024-2036
Table 15: Prenatal Screening Market, China, Revenue ($m), USD Constant, 2024-2036
Table 16: Reproductive Hormones and Proteins Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Table 17: Reproductive Health Diagnostics Market, China, Volume (Units), 2024-2036
Table 18: Prenatal Screening Market, China, Volume (Units), 2024-2036
Table 19: Reproductive Hormones and Proteins Tests Market, China, Volume (Units), 2024-2036
Table 20: Reproductive Health Diagnostics Market, China, Average Price ($), 2024-2036
Table 21: Reproductive Health Diagnostics Market, China, Company Share by Revenue ($m), USD Constant, 2025
Table 22: Reproductive Health Diagnostics Market, India, Revenue ($m), USD Constant, 2024-2036
Table 23: Prenatal Screening Market, India, Revenue ($m), USD Constant, 2024-2036
Table 24: Reproductive Hormones and Proteins Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Table 25: Reproductive Health Diagnostics Market, India, Volume (Units), 2024-2036
Table 26: Prenatal Screening Market, India, Volume (Units), 2024-2036
Table 27: Reproductive Hormones and Proteins Tests Market, India, Volume (Units), 2024-2036
Table 28: Reproductive Health Diagnostics Market, India, Average Price ($), 2024-2036
Table 29: Reproductive Health Diagnostics Market, India, Company Share by Revenue ($m), USD Constant, 2025
Table 30: Reproductive Health Diagnostics Market, Russia, Revenue ($m), USD Constant, 2024-2036
Table 31: Prenatal Screening Market, Russia, Revenue ($m), USD Constant, 2024-2036
Table 32: Reproductive Hormones and Proteins Tests Market, Russia, Revenue ($m), USD Constant, 2024-2036
Table 33: Reproductive Health Diagnostics Market, Russia, Volume (Units), 2024-2036
Table 34: Prenatal Screening Market, Russia, Volume (Units), 2024-2036
Table 35: Reproductive Hormones and Proteins Tests Market, Russia, Volume (Units), 2024-2036
Table 36: Reproductive Health Diagnostics Market, Russia, Average Price ($), 2024-2036
Table 37: Reproductive Health Diagnostics Market, Russia, Company Share by Revenue ($m), USD Constant, 2025
Table 38: Reproductive Health Diagnostics Market Pipeline Products
Table 39: Reproductive Health Diagnostics - Pipeline Products by Stage of Development
Table 40: Reproductive Health Diagnostics Companies - Pipeline Products by Stage of Development
Table 41: Reproductive Health Diagnostics - Pipeline Products by Segment
Table 42: Reproductive Health Diagnostics - Pipeline Products by Territory
Table 43: Reproductive Health Diagnostics - Pipeline Products by Regulatory Path
Table 44: Reproductive Health Diagnostics - Pipeline Products by Estimated Approval Date
Table 45: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Reproductive Health Diagnostics Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2024-2036
Figure 2: Reproductive Health Diagnostics Market, BRIC, Revenue ($m), USD Constant, 2024-2036
Figure 3: Reproductive Health Diagnostics Market, BRIC, Volume (Units), 2024-2036
Figure 4: Reproductive Health Diagnostics Market, BRIC, Volume (Units), 2024-2036
Figure 5: Reproductive Health Diagnostics Market, BRIC, Company Share (%), 2025
Figure 6: Reproductive Health Diagnostics Market, Brazil, Revenue ($m), USD Constant, 2024-2036
Figure 7: Prenatal Screening Market, Brazil, Revenue ($m), USD Constant, 2024-2036
Figure 8: Reproductive Hormones and Proteins Tests Market, Brazil, Revenue ($m), USD Constant, 2024-2036
Figure 9: Reproductive Health Diagnostics Market, Brazil, Volume (Units), 2024-2036
Figure 10: Prenatal Screening Market, Brazil, Volume (Units), 2024-2036
Figure 11: Reproductive Hormones and Proteins Tests Market, Brazil, Volume (Units), 2024-2036
Figure 12: Reproductive Health Diagnostics Market, Brazil, Company Share (%), 2025
Figure 13: Reproductive Health Diagnostics Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 14: Prenatal Screening Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 15: Reproductive Hormones and Proteins Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 16: Reproductive Health Diagnostics Market, China, Volume (Units), 2024-2036
Figure 17: Prenatal Screening Market, China, Volume (Units), 2024-2036
Figure 18: Reproductive Hormones and Proteins Tests Market, China, Volume (Units), 2024-2036
Figure 19: Reproductive Health Diagnostics Market, China, Company Share (%), 2025
Figure 20: Reproductive Health Diagnostics Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 21: Prenatal Screening Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 22: Reproductive Hormones and Proteins Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 23: Reproductive Health Diagnostics Market, India, Volume (Units), 2024-2036
Figure 24: Prenatal Screening Market, India, Volume (Units), 2024-2036
Figure 25: Reproductive Hormones and Proteins Tests Market, India, Volume (Units), 2024-2036
Figure 26: Reproductive Health Diagnostics Market, India, Company Share (%), 2025
Figure 27: Reproductive Health Diagnostics Market, Russia, Revenue ($m), USD Constant, 2024-2036
Figure 28: Prenatal Screening Market, Russia, Revenue ($m), USD Constant, 2024-2036
Figure 29: Reproductive Hormones and Proteins Tests Market, Russia, Revenue ($m), USD Constant, 2024-2036
Figure 30: Reproductive Health Diagnostics Market, Russia, Volume (Units), 2024-2036
Figure 31: Prenatal Screening Market, Russia, Volume (Units), 2024-2036
Figure 32: Reproductive Hormones and Proteins Tests Market, Russia, Volume (Units), 2024-2036
Figure 33: Reproductive Health Diagnostics Market, Russia, Company Share (%), 2025
Figure 34: Reproductive Health Diagnostics - Pipeline Products by Stage of Development
Figure 35: Reproductive Health Diagnostics - Pipeline Products by Segment
Figure 36: Reproductive Health Diagnostics - Pipeline Products by Territory
Figure 37: Reproductive Health Diagnostics - Pipeline Products by Regulatory Path
Figure 38: Reproductive Health Diagnostics - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Beckman Coulter Inc
  • Illumina Inc
  • Quidel Corp
  • Roche Diagnostics International Ltd
  • BGI Genomics Co Ltd
  • Siemens Healthineers AG
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Danaher Corp
  • Thermo Fisher Scientific Inc